Global Adult Vaccines Market Size
Pharmaceuticals

Global Adult Vaccines Market Analysis: Estimated Market Size And Growth Rate

The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The global adult vaccines market is set for robust growth, with projections indicating an increase from $18.20 billion in 2022 to $19.56 billion in 2023 at a CAGR of 7.49%. Looking ahead, the market is poised to reach $25.83 billion by 2027, sustaining a CAGR of 7.20%.

  • Yearly Growth Snapshot: Expected to grow from $18.20 billion in 2022 to $19.56 billion in 2023.
  • Long-Term Outlook: Anticipated market size of $25.83 billion by 2027.

Containing Contagion: Driving Force of Increasing Prevalence
The surging prevalence of contagious diseases globally is a prime driver for the adult vaccines market. Contagious diseases, known for their person-to-person transmission, pose significant health threats. Vaccines play a crucial role in building immunity and combating infections, making them a cornerstone in the battle against contagious diseases.

  • COVID-19 Impact: 655 million people infected with COVID-19 globally, emphasizing the need for effective vaccines.
  • Tuberculosis Challenges: In 2021, 1.3 million non-HIV-related deaths occurred due to TB, highlighting the ongoing threat of infectious diseases.

Industry Giants: Key Players Shaping the Landscape
Major players in the adult vaccines market wield influence through their contributions to research, development, and distribution. These companies are instrumental in driving advancements and ensuring widespread access to adult vaccines.

  • Prominent Market Players: GlaxoSmithKline PLC, Merck & Co, Sanofi Pasteur, Pfizer Inc., Johnson & Johnson, and more.
  • Global Impact: These players contribute significantly to addressing global health challenges through vaccine development.

Innovations for Impact: Product Trends in Adult Vaccines
Product innovation stands out as a key trend in the adult vaccines market, with major companies introducing groundbreaking solutions to maintain a competitive edge. A notable example is the U.S. Food and Drug Administration’s approval of Sanofi’s MenQuadfi vaccine in April 2020.

  • MenQuadfi Approval: First quadrivalent vaccine with high immune response for all four serogroups of Meningococcus bacteria.
  • Continuous Advancements: Ongoing efforts to introduce innovative products underscore the commitment to effective and accessible adult vaccines.

Market Segmentation: Understanding Diverse Needs
The adult vaccines market caters to diverse needs, leading to a comprehensive segmentation based on vaccine type, technology, application, and end-users.

  1. By Vaccine Type:
    • Monovalent
    • Multivalent
  2. By Technology:
    • Live Attenuated Vaccines
    • Inactivated Viral or Bacterial Vaccines
    • Toxoid Vaccines
    • Recombinant Vaccines
    • Conjugate Vaccines
  3. By Application:
    • Influenza
    • DPT
    • Human Papillomavirus
    • Zoster
    • Pneumococcal
    • Hepatitis
  4. By End Users:
    • Healthcare Firms
    • Hospitals

Regional Dynamics: North America Leading, Asia-Pacific Rising
Regional dynamics play a crucial role in shaping the adult vaccines market landscape. North America holds the largest share in 2022, while Asia-Pacific emerges as the fastest-growing region during the forecast period.

  • North American Dominance: Largest market share in 2022.
  • Asia-Pacific Growth: Anticipated to be the fastest-growing region, reflecting increasing awareness and healthcare developments.

View More On The Adult Vaccines Market Report 2023 – https://www.thebusinessresearchcompany.com/report/adult-vaccines-global-market-report

Request A Sample Of The Global Adult Vaccines Market Report 2023:
https://www.thebusinessresearchcompany.com/sample_request?id=9038&type=smp

The Adult Vaccines Global Market Report 2023  provides a comprehensive overview on the adult vaccines market size, trends and drivers, opportunities, strategies, and companies analysis. The countries covered in the adult vaccines market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Electronic Design Automation Software Global Market Report 2023
Product Engineering Services Global Market Report 2023
Network Engineering Services Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model